ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
(NASDAQ: SPRY) Delayed: 4.15 -0.01 (0.24%)
Previous Close $4.16    52 Week High $ 
Open $4.26    52 Week Low $ 
Day High $4.30    P/E N/A 
Day Low $4.12    EPS $ 
Volume 1,870,621